6.91
5.66%
+0.37
Dopo l'orario di chiusura:
6.82
-0.09
-1.30%
NeuroPace Inc Borsa (NPCE) Ultime notizie
Wells Fargo maintains Overweight on NeuroPace with $20 target By Investing.com - Investing.com
Investing.com
NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference - The Globe and Mail
The Globe and Mail
Market Watch Highlights: NeuroPace Inc (NPCE) Ends on an Downturn Note at 7.53 – DWinneX - The Dwinnex
The Dwinnex
NeuroPace, Inc.'s (NASDAQ:NPCE) top owners are private equity firms with 47% stake, while 24% is held by institutions - Yahoo Finance
Yahoo Finance
Trend Tracker for (NPCE) - Stock Traders Daily
Stock Traders Daily
Bear of the Day: NeuroPace (NPCE) - Yahoo New Zealand News
Yahoo New Zealand News
Contrasting Tactile Systems Technology (NASDAQ:TCMD) and NeuroPace (NASDAQ:NPCE) - Defense World
Defense World
NeuroPace (NPCE) Price Target Increased by 17.52% to 9.35 - MSN
MSN
NeuroPace (NASDAQ:NPCE) adds US$17m to market cap in the past 7 days, though investors from a year ago are still ... - Yahoo Movies UK
Yahoo Movies UK
NeuroPace to Participate in Two Healthcare Conferences in May - Investing.com India
Investing.com India
Q2 2024 Earnings Forecast for NeuroPace, Inc. (NASDAQ:NPCE) Issued By Leerink Partnrs - MarketBeat
MarketBeat
Brain Computer Interface Technology Market 2024 Trends with Analysis on Key Players NeuroPace Inc, Emotiv Inc ... - Amoré
Amoré
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
NeuroPace's (NPCE) Overweight Rating Reaffirmed at Cantor Fitzgerald - Defense World
Defense World
Q2 2024 Earnings Forecast for NeuroPace, Inc. (NASDAQ:NPCE) Issued By Leerink Partnrs - MarketBeat
MarketBeat
Q2 2024 EPS Estimates for NeuroPace, Inc. Decreased by Analyst (NASDAQ:NPCE) - Defense World
Defense World
Earnings call: NeuroPace sees strong Q1 revenue growth, eyes RNS system expansion By Investing.com - Investing.com Canada
Investing.com Canada
Earnings call: NeuroPace sees strong Q1 revenue growth, eyes RNS system expansion - Investing.com India
Investing.com India
FY2028 Earnings Estimate for NeuroPace, Inc. Issued By Leerink Partnrs (NASDAQ:NPCE) - Defense World
Defense World
NeuroPace, Inc. (NPCE) Q1 2024 Earnings Call Transcript - Seeking Alpha
Seeking Alpha
Have Insiders Been Buying NeuroPace, Inc. (NASDAQ:NPCE) Shares? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
NeuroPace, Inc. to Post FY2028 Earnings of $0.27 Per Share, Leerink Partnrs Forecasts (NASDAQ:NPCE) - MarketBeat
MarketBeat
NeuroPace First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Simply Wall St
Brain Computer Interfaces in Medicine Market 2031 Key Insights and Leading Players NeuroPace, Inc, Mindmaze - Motions Online
Motions Online
NeuroPace, Inc. to Post FY2028 Earnings of $0.27 Per Share, Leerink Partnrs Forecasts (NASDAQ:NPCE) - MarketBeat
MarketBeat
Neuropace's Financial Health: Navigating Risks Tied to RNS System Dominance and Supplier Dependencies ... - TipRanks
TipRanks
NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
MarketBeat
NeuroPace (NASDAQ:NPCE) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
MarketBeat
NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Defense World
NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
MarketBeat
NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update - 08.05.2024 - wallstreet:online
wallstreet:online
Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research
Bear of the Day: NeuroPace (NPCE) - Yahoo New Zealand News
Yahoo New Zealand News
NeuroPace (NPCE) Set to Announce Quarterly Earnings on Wednesday - Defense World
Defense World
Orbimed Advisors Llc Sells 4,674 Shares of NeuroPace, Inc. (NASDAQ:NPCE) Stock - MarketBeat
MarketBeat
Brain Computer Interfaces in Medicine Market 2024 [Key Trends] | NeuroPace Inc, Mindmaze SA, G.TEC - Motions Online
Motions Online
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
GlobeNewswire Inc.
OrbiMed Advisors sells over $7 million in NeuroPace stock - Investing.com South Africa
Investing.com South Africa
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
GlobeNewswire Inc.
The Latest Analyst Ratings For NeuroPace
Benzinga
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Neuropace, Inc.'s New Economy & Political Environment Risk – A Cause for Worry? - TipRanks.com - TipRanks
TipRanks
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
GlobeNewswire Inc.
Neuropace earnings beat by $0.09, revenue topped estimates - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
A Glimpse Into The Expert Outlook On NeuroPace Through 4 Analysts
Benzinga
NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
GlobeNewswire Inc.
NeuroPace Announces Chief Legal Officer Irina Ridley's Departure - TipRanks.com - TipRanks
TipRanks
CLO Of Epilepsy Treatment Biz NeuroPace To Depart - Law360
Law360
NeuroPace Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Benzinga
Capitalizzazione:
|
Volume (24 ore):